In this episode, host Dr. Mike Nickels welcomes nuclear medicine pioneer Dr. Richard Wahl for an in-depth exploration of alpha-emitting radiopharmaceuticals. Learn where alpha therapy holds the most clinical promise, and what’s needed to bring these powerful agents into routine care. From supply chain hurdles to toxicity management and future clinical applications, this conversation offers expert insight into one of the most exciting—and complex—frontiers in nuclear medicine.

In this inaugural episode of the WMIS Podcast, Dr. Mike Nickels sits down with Dr. Diane Abou of NorthStar Medical Radioisotopes for a dynamic conversation about the rise of theranostics in nuclear medicine. Tune in as they unpack what theranostics really means, why it’s gaining momentum, and how it's transforming the future of patient care. Learn about clinical applications, key challenges in isotope production, and why this is such an exciting time for the field.